vs

Side-by-side financial comparison of LifeMD, Inc. (LFMD) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $7.1M, roughly 20.0× LifeMD, Inc.). LifeMD, Inc. runs the higher net margin — 282.0% vs -5.3%, a 287.3% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 5.0%). Oncology Institute, Inc. produced more free cash flow last quarter ($2.2M vs $-3.4M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs -60.0%).

SBI Life Insurance Company Limited is an Indian life insurance company. It was started as a joint venture between State Bank of India (SBI) and French financial institution BNP Paribas Cardif.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

LFMD vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
20.0× larger
TOI
$142.0M
$7.1M
LFMD
Growing faster (revenue YoY)
TOI
TOI
+36.6% gap
TOI
41.6%
5.0%
LFMD
Higher net margin
LFMD
LFMD
287.3% more per $
LFMD
282.0%
-5.3%
TOI
More free cash flow
TOI
TOI
$5.6M more FCF
TOI
$2.2M
$-3.4M
LFMD
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
-60.0%
LFMD

Income Statement — Q4 2025 vs Q4 2025

Metric
LFMD
LFMD
TOI
TOI
Revenue
$7.1M
$142.0M
Net Profit
$20.0M
$-7.5M
Gross Margin
40.2%
Operating Margin
-87.9%
-4.9%
Net Margin
282.0%
-5.3%
Revenue YoY
5.0%
41.6%
Net Profit YoY
742.5%
43.0%
EPS (diluted)
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LFMD
LFMD
TOI
TOI
Q4 25
$7.1M
$142.0M
Q3 25
$60.2M
$136.6M
Q2 25
$62.7M
$119.8M
Q1 25
$64.1M
$104.4M
Q4 24
$6.7M
$100.3M
Q3 24
$53.3M
$99.9M
Q2 24
$50.7M
$98.6M
Q1 24
$44.1M
$94.7M
Net Profit
LFMD
LFMD
TOI
TOI
Q4 25
$20.0M
$-7.5M
Q3 25
$-3.8M
$-16.5M
Q2 25
$-1.6M
$-17.0M
Q1 25
$-183.8K
$-19.6M
Q4 24
$-3.1M
$-13.2M
Q3 24
$-4.7M
$-16.1M
Q2 24
$-6.9M
$-15.5M
Q1 24
$-6.8M
$-19.9M
Gross Margin
LFMD
LFMD
TOI
TOI
Q4 25
40.2%
Q3 25
87.7%
Q2 25
88.1%
Q1 25
86.5%
Q4 24
-0.8%
Q3 24
90.6%
Q2 24
90.1%
Q1 24
89.6%
Operating Margin
LFMD
LFMD
TOI
TOI
Q4 25
-87.9%
-4.9%
Q3 25
-3.3%
-5.9%
Q2 25
-0.7%
-9.4%
Q1 25
1.5%
-9.5%
Q4 24
-58.2%
-11.9%
Q3 24
-7.5%
-13.9%
Q2 24
-12.4%
-16.6%
Q1 24
-14.0%
-19.0%
Net Margin
LFMD
LFMD
TOI
TOI
Q4 25
282.0%
-5.3%
Q3 25
-6.3%
-12.1%
Q2 25
-2.6%
-14.2%
Q1 25
-0.3%
-18.8%
Q4 24
-46.1%
-13.1%
Q3 24
-8.7%
-16.1%
Q2 24
-13.6%
-15.7%
Q1 24
-15.3%
-21.0%
EPS (diluted)
LFMD
LFMD
TOI
TOI
Q4 25
$-0.04
Q3 25
$-0.14
Q2 25
$-0.05
$-0.15
Q1 25
$-0.02
$-0.21
Q4 24
$-0.14
Q3 24
$-0.13
$-0.18
Q2 24
$-0.17
Q1 24
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LFMD
LFMD
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
Stockholders' EquityBook value
$23.2M
$-15.7M
Total Assets
$70.4M
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LFMD
LFMD
TOI
TOI
Q4 25
Q3 25
Q2 25
$36.2M
Q1 25
$34.4M
Q4 24
$35.0M
Q3 24
$37.6M
Q2 24
$35.7M
$9.9M
Q1 24
$35.1M
$29.8M
Total Debt
LFMD
LFMD
TOI
TOI
Q4 25
Q3 25
Q2 25
$15.9M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
LFMD
LFMD
TOI
TOI
Q4 25
$23.2M
$-15.7M
Q3 25
$1.3M
$-12.3M
Q2 25
$-1.8M
$-9.0M
Q1 25
$-2.3M
$5.1M
Q4 24
$-9.1M
$3.6M
Q3 24
$-7.7M
$15.5M
Q2 24
$-4.2M
$29.2M
Q1 24
$-845.3K
$41.3M
Total Assets
LFMD
LFMD
TOI
TOI
Q4 25
$70.4M
$164.7M
Q3 25
$66.0M
$163.6M
Q2 25
$73.6M
$159.8M
Q1 25
$73.6M
$164.0M
Q4 24
$76.1M
$172.7M
Q3 24
$72.6M
$179.2M
Q2 24
$63.8M
$179.6M
Q1 24
$61.5M
$204.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LFMD
LFMD
TOI
TOI
Operating Cash FlowLast quarter
$-3.3M
$3.2M
Free Cash FlowOCF − Capex
$-3.4M
$2.2M
FCF MarginFCF / Revenue
-48.5%
1.5%
Capex IntensityCapex / Revenue
2.2%
0.7%
Cash ConversionOCF / Net Profit
-0.16×
TTM Free Cash FlowTrailing 4 quarters
$6.4M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LFMD
LFMD
TOI
TOI
Q4 25
$-3.3M
$3.2M
Q3 25
$-147.1K
$-12.6M
Q2 25
$8.6M
$-10.2M
Q1 25
$3.1M
$-5.0M
Q4 24
$1.1M
$4.2M
Q3 24
$6.7M
$819.0K
Q2 24
$4.5M
$-15.7M
Q1 24
$5.2M
$-15.9M
Free Cash Flow
LFMD
LFMD
TOI
TOI
Q4 25
$-3.4M
$2.2M
Q3 25
$-944.4K
$-13.2M
Q2 25
$7.8M
$-11.4M
Q1 25
$2.9M
$-5.3M
Q4 24
$875.4K
$2.4M
Q3 24
$6.3M
$417.0K
Q2 24
$3.9M
$-17.5M
Q1 24
$5.0M
$-16.5M
FCF Margin
LFMD
LFMD
TOI
TOI
Q4 25
-48.5%
1.5%
Q3 25
-1.6%
-9.7%
Q2 25
12.5%
-9.5%
Q1 25
4.6%
-5.1%
Q4 24
13.0%
2.4%
Q3 24
11.7%
0.4%
Q2 24
7.7%
-17.7%
Q1 24
11.4%
-17.4%
Capex Intensity
LFMD
LFMD
TOI
TOI
Q4 25
2.2%
0.7%
Q3 25
1.3%
0.4%
Q2 25
1.3%
1.0%
Q1 25
0.2%
0.3%
Q4 24
2.9%
1.8%
Q3 24
0.8%
0.4%
Q2 24
1.3%
1.9%
Q1 24
0.4%
0.6%
Cash Conversion
LFMD
LFMD
TOI
TOI
Q4 25
-0.16×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LFMD
LFMD

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons